Prospects for plasma protein products in China

Autor:	Changyong JIAN, Fangyu DONG, Chen CHEN, An ZHOU, Jiuyue ZHOU, Xue DONG, Cuiping ZHANG, Dianwei SONG, Bo ZHOU, Shan MA
Jazyk:	čínština
Rok vydání:	2022
Předmět:	plasma protein products immunoglobulin von willebrand factor complex anti-inhibitor coagulant complex human antithrombin ⅲ c1 esterase inhibitor Diseases of the blood and blood-forming organs RC633-647.5 Medicine
Zdroj:	Zhongguo shuxue zazhi, Vol 35, Iss 2, Pp 227-232 (2022)
Druh dokumentu:	article
ISSN:	1004-549X 1004-549x
DOI:	10.13303/j.cjbt.issn.1004-549x.2022.02.027&lang=en
Popis:	Plasma protein products, essential drugs for various clinical diseases, are therapeutic biological products extracted from healthy human plasma. The research and development of new plasma protein products, led by United States and European, has been widely deepened and enhanced. Therefore, accelerating the development of new plasma protein products in China is of great significance. This review summarizes the research and development of plasma protein products that have been marketed abroad but have not produced in China, as well as analyzes the difficulties and prospects of the development of plasma protein products in China.
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/a62c31b4478345f8b568043bcf4f4f00 Zobrazit plný text záznamu View record in DOAJ